| Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis JD Sobel, HC Wiesenfeld, M Martens, P Danna, TM Hooton, A Rompalo, ... New England Journal of Medicine 351 (9), 876-883, 2004 | 645 | 2004 |
| Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial DB Van Wyck, MG Martens, MH Seid, JB Baker, A Mangione Obstetrics & Gynecology 110 (2 Part 1), 267-278, 2007 | 358 | 2007 |
| Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial DB Van Wyck, MG Martens, MH Seid, JB Baker, A Mangione Obstetrics & Gynecology 110 (2 Part 1), 267-278, 2007 | 357 | 2007 |
| Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind … CM Wheeler, SR Skinner, MR Del Rosario-Raymundo, SM Garland, ... The Lancet infectious diseases 16 (10), 1154-1168, 2016 | 215 | 2016 |
| Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double … SR Skinner, A Szarewski, B Romanowski, SM Garland, E Lazcano-Ponce, ... The Lancet 384 (9961), 2213-2227, 2014 | 215 | 2014 |
| Development of wound infection or separation after cesarean delivery. Prospective evaluation of 2,431 cases MG Martens, BL Kolrud, S Faro, M Maccato, H Hammill The Journal of reproductive medicine 40 (3), 171-175, 1995 | 169 | 1995 |
| The impact of liquid-based cytology in decreasing the incidence of cervical cancer RK Gibb, MG Martens Reviews in Obstetrics and Gynecology 4 (Suppl 1), S2, 2011 | 160 | 2011 |
| Clinical validation of the Cervista® HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology MH Einstein, MG Martens, FAR Garcia, DG Ferris, AL Mitchell, SP Day, ... Gynecologic oncology 118 (2), 116-122, 2010 | 146 | 2010 |
| Clinical validation of the Cervista® HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology MH Einstein, MG Martens, FAR Garcia, DG Ferris, AL Mitchell, SP Day, ... Gynecologic oncology 118 (2), 116-122, 2010 | 146 | 2010 |
| Expression of complement regulatory proteins—CD 35, CD 46, CD 55, and CD 59—in benign and malignant endometrial tissue KP Murray, S Mathure, R Kaul, S Khan, LF Carson, LB Twiggs, ... Gynecologic oncology 76 (2), 176-182, 2000 | 125 | 2000 |
| Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. JM Hanson, JA McGregor, SL Hillier, DA Eschenbach, AK Kreutner, ... The Journal of reproductive medicine 45 (11), 889-896, 2000 | 115 | 2000 |
| Vaginal flora and pelvic inflammatory disease S Faro, M Martens, M Maccato, H Hammill, M Pearlman American journal of obstetrics and gynecology 169 (2), 470-474, 1993 | 114 | 1993 |
| Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial G de Bruyn, J Saleh, D Workman, R Pollak, V Elinoff, NJ Fraser, ... Vaccine 34 (19), 2170-2178, 2016 | 102 | 2016 |
| Antibiotic prophylaxis: is there a difference? S Faro, MG Martens, HA Hammill, G Riddle, G Tortolero American journal of obstetrics and gynecology 162 (4), 900-909, 1990 | 101 | 1990 |
| Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation A Szarewski, SR Skinner, SM Garland, B Romanowski, TF Schwarz, ... The Journal of infectious diseases 208 (9), 1391-1396, 2013 | 94 | 2013 |
| Imiquimod 3.75% cream applied daily to treat anogenital warts: combined results from women in two randomized, placebo-controlled studies DA Baker, DG Ferris, MG Martens, KH Fife, SK Tyring, L Edwards, ... Infectious diseases in obstetrics and gynecology 2011, 2011 | 75 | 2011 |
| Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis CH LIVENGOOD III, DE Soper, KL Sheehan, DE Fenner, MG Martens, ... Sexually transmitted diseases, 137-142, 1999 | 69 | 1999 |
| Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group. MG Martens, S Gordon, DR Yarborough, S Faro, D Binder, A Berkeley Southern medical journal 86 (6), 604-610, 1993 | 68 | 1993 |
| Experimental gestational pyelonephritis induces preterm births and low birth weights in C3H/HeJ mice AK Kaul, S Khan, MG Martens, JT Crosson, VR Lupo, R Kaul Infection and immunity 67 (11), 5958-5966, 1999 | 57 | 1999 |
| Concerns regarding the Centers for Disease Control's published guidelines for pelvic inflammatory disease DL Hemsel, WJ Ledger, M Martens, GRG Monif, NG Osborne, ... Clinical infectious diseases 32 (1), 103-107, 2001 | 56 | 2001 |
